Opioid biomarkers in urine as reliable and valid correlates of opium use characteristics: A 10-year longitudinal assessment

IF 2.9
Mahdokht Naghash , Rebecca L. Shaner , Hossein Poustchi , Gholamreza Roshandel , Katrice D. Williams , Abraham Tuachi , Farin Kamangar , Paolo Boffetta , Christian C. Abnet , Elizabeth I. Hamelin , Neal D. Freedman , Reza Malekzadeh , Arash Etemadi
{"title":"Opioid biomarkers in urine as reliable and valid correlates of opium use characteristics: A 10-year longitudinal assessment","authors":"Mahdokht Naghash ,&nbsp;Rebecca L. Shaner ,&nbsp;Hossein Poustchi ,&nbsp;Gholamreza Roshandel ,&nbsp;Katrice D. Williams ,&nbsp;Abraham Tuachi ,&nbsp;Farin Kamangar ,&nbsp;Paolo Boffetta ,&nbsp;Christian C. Abnet ,&nbsp;Elizabeth I. Hamelin ,&nbsp;Neal D. Freedman ,&nbsp;Reza Malekzadeh ,&nbsp;Arash Etemadi","doi":"10.1016/j.dadr.2025.100377","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Biomarkers can clarify the mechanistic bases of health effects associated with opiate use and improve evaluating dose-response relationships by quantifying the absorbed dose through different routes and patterns of use, supporting the generalizability of opium research findings to broader opioid use.</div></div><div><h3>Methods</h3><div>We recruited 449 individuals who used opium and 66 individuals who did not, 10 years after baseline evaluation in a cohort study. At both time points, we collected self-reported characteristics of opium use (route, frequency, type, and dose) and measured urinary concentrations of codeine, hydrocodone, hydromorphone, morphine, morphine-3-glucuronide, and morphine-6-glucuronide in spot urine samples. We used multivariate linear regression models to determine the independent effects of each opium use characteristic on biomarker concentrations. Reliability of biomarker concentrations over the 10-year interval was assessed using intraclass correlation coefficients (ICCs) from linear mixed-effect models.</div></div><div><h3>Results</h3><div>At the follow-up, 229 (51.0 %) subjects used opium by ingestion, which showed a significant shift compared with baseline (24.4 % ingestion). In adjusted models, opium ingestion, daily use, and presence of opioid use disorder (OUD) were associated with higher concentrations of all opioid biomarkers compared with opium smoking, non-daily use, and absence of OUD, respectively. All opioid biomarkers showed significant dose-response relationships relative to self-reported doses. Biomarker concentrations peaked when opium was used 3–4<!--> <!-->h before sample collection and declined afterwards, remaining detectable for several days. Biomarker measurements were reliable (ICCs between 0.69 and 0.78) over the 10-year interval.</div></div><div><h3>Conclusions</h3><div>Opioid biomarkers are valid markers of lifetime history, route, frequency, dose, and recency of opium use and OUD diagnosis, and demonstrate good long-term reliability.</div></div>","PeriodicalId":72841,"journal":{"name":"Drug and alcohol dependence reports","volume":"17 ","pages":"Article 100377"},"PeriodicalIF":2.9000,"publicationDate":"2025-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug and alcohol dependence reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772724625000605","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Biomarkers can clarify the mechanistic bases of health effects associated with opiate use and improve evaluating dose-response relationships by quantifying the absorbed dose through different routes and patterns of use, supporting the generalizability of opium research findings to broader opioid use.

Methods

We recruited 449 individuals who used opium and 66 individuals who did not, 10 years after baseline evaluation in a cohort study. At both time points, we collected self-reported characteristics of opium use (route, frequency, type, and dose) and measured urinary concentrations of codeine, hydrocodone, hydromorphone, morphine, morphine-3-glucuronide, and morphine-6-glucuronide in spot urine samples. We used multivariate linear regression models to determine the independent effects of each opium use characteristic on biomarker concentrations. Reliability of biomarker concentrations over the 10-year interval was assessed using intraclass correlation coefficients (ICCs) from linear mixed-effect models.

Results

At the follow-up, 229 (51.0 %) subjects used opium by ingestion, which showed a significant shift compared with baseline (24.4 % ingestion). In adjusted models, opium ingestion, daily use, and presence of opioid use disorder (OUD) were associated with higher concentrations of all opioid biomarkers compared with opium smoking, non-daily use, and absence of OUD, respectively. All opioid biomarkers showed significant dose-response relationships relative to self-reported doses. Biomarker concentrations peaked when opium was used 3–4 h before sample collection and declined afterwards, remaining detectable for several days. Biomarker measurements were reliable (ICCs between 0.69 and 0.78) over the 10-year interval.

Conclusions

Opioid biomarkers are valid markers of lifetime history, route, frequency, dose, and recency of opium use and OUD diagnosis, and demonstrate good long-term reliability.
尿液中的阿片类生物标志物作为鸦片使用特征的可靠和有效的相关性:一项10年的纵向评估
生物标志物可以阐明与阿片类药物使用相关的健康影响的机制基础,并通过量化不同途径和使用模式的吸收剂量来改善评估剂量-反应关系,支持鸦片研究结果推广到更广泛的阿片类药物使用。方法:在基线评估10年后,我们在队列研究中招募了449名使用鸦片的个体和66名未使用鸦片的个体。在这两个时间点,我们收集了自我报告的鸦片使用特征(途径、频率、类型和剂量),并测量了尿样中可待因、氢可酮、氢吗啡酮、吗啡、吗啡-3-葡糖苷和吗啡-6-葡糖苷的尿浓度。我们使用多元线性回归模型来确定每个鸦片使用特征对生物标志物浓度的独立影响。使用线性混合效应模型的类内相关系数(ICCs)评估10年期间生物标志物浓度的可靠性。结果随访中,229例(51.0%)的受试者摄入鸦片,与基线(24.4%)相比有显著变化。在调整后的模型中,鸦片摄入、日常使用和阿片样物质使用障碍(OUD)的存在与所有阿片样物质生物标志物的浓度分别高于鸦片吸烟、非日常使用和不存在OUD。所有阿片类药物生物标志物均与自我报告的剂量表现出显著的剂量-反应关系。在采集样本前3-4小时使用鸦片时,生物标志物浓度达到峰值,随后下降,可检测数天。在10年的时间间隔内,生物标志物测量是可靠的(ICCs在0.69至0.78之间)。结论类鸦片生物标志物是鸦片使用史、途径、频率、剂量、近期及OUD诊断的有效标志物,具有良好的长期可靠性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Drug and alcohol dependence reports
Drug and alcohol dependence reports Psychiatry and Mental Health
自引率
0.00%
发文量
0
审稿时长
100 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信